review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1007/S007870070019 |
P8608 | Fatcat ID | release_fh52ofw2grghjfop4skvi75o5a |
P698 | PubMed publication ID | 11140780 |
P50 | author | Joseph Biederman | Q6281524 |
P2093 | author name string | Spencer T | |
P2860 | cites work | Combining methylphenidate and clonidine: a clinically sound medication option | Q77406042 |
Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder | Q77750690 | ||
A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder | Q28139660 | ||
Nortriptyline treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome | Q28265765 | ||
Nortriptyline in the treatment of ADHD: a chart review of 58 cases | Q28266782 | ||
Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association | Q28267877 | ||
An open clinical trial of buspirone in children with attention-deficit/hyperactivity disorder | Q28268203 | ||
Carbamazepine use in children and adolescents with features of attention-deficit hyperactivity disorder: a meta-analysis | Q28285139 | ||
One-year follow-up of hyperactive boys treated with imipramine or methylphenidate | Q28336538 | ||
Risperidone treatment for juvenile bipolar disorder: a retrospective chart review | Q33703978 | ||
Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder | Q33814162 | ||
Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder? | Q33869980 | ||
A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder | Q33923100 | ||
Hyperactive boys almost grown up. I. Psychiatric status | Q34199819 | ||
Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children | Q34272419 | ||
Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. | Q34423030 | ||
Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose | Q34424765 | ||
Nicotine chewing gum (2 mg, 4 mg) and cigarette smoking: comparative effects upon vigilance and heart rate | Q34427598 | ||
A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy | Q34509110 | ||
Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder | Q34662955 | ||
Genetic factors in hyperactivity | Q38229261 | ||
Nicotine effects on adults with attention-deficit/hyperactivity disorder | Q39469194 | ||
A review of stimulant drug research with hyperactive children | Q39624696 | ||
Amitriptyline and methylphenidate treatment of behaviorally disordered children | Q40751150 | ||
Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders | Q40881907 | ||
Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience | Q40975079 | ||
Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity | Q41211796 | ||
Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle | Q41214134 | ||
Is attention deficit hyperactivity disorder familial? | Q41652620 | ||
The use of imipramine in Tourette's syndrome and attention deficit disorder: case report | Q42201286 | ||
Imipramine and methylphenidate treatments of hyperactive boys. A double-blind comparison | Q42233692 | ||
An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder | Q42690067 | ||
Family-environment risk factors for attention-deficit hyperactivity disorder. A test of Rutter's indicators of adversity | Q43708009 | ||
Cholinergic modulation of the content of temporal memory | Q44175088 | ||
Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder | Q44362998 | ||
Desipramine in the treatment of children with attention deficit disorder | Q44664982 | ||
Treatment of ADHD with fluoxetine: a preliminary trial. | Q45018932 | ||
Epinephrine and norepinephrine act as potent agonists at the recombinant human dopamine D4 receptor | Q47037371 | ||
Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine | Q48205587 | ||
Imipramine in the Treatment of Minimal Brain Dysfunction in Children | Q48632490 | ||
Effects of Imipramine and Dextroamphetamine on Behavior of Neuropsychiatrically Impaired Children | Q48771000 | ||
Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptors | Q48856963 | ||
Attention, memory, and cigarette smoking | Q49032141 | ||
Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial | Q49036879 | ||
Behavioral effects of prenatal exposure to nicotine in guinea pigs. | Q49091073 | ||
Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. | Q51017485 | ||
The Personality Inventory for Children and response to methylphenidate: preliminary evidence for predictive utility. | Q51241580 | ||
Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. | Q52035084 | ||
Methylphenidate and desipramine in hospitalized children: I. Separate and combined effects on cognitive function. | Q52037711 | ||
Bupropion hydrochloride in attention deficit disorder with hyperactivity. | Q52046328 | ||
Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. | Q52046529 | ||
Differential Effects of Methylphenidate on Working Memory in ADHD Children with and without Comorbid Anxiety | Q52052538 | ||
Hyperactive boys almost grown up. V. Replication of psychiatric status. | Q52053175 | ||
Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. | Q52089747 | ||
Effect of anxiety on cognition, behavior, and stimulant response in ADHD. | Q52112767 | ||
A pilot study of nadolol for overt aggression in developmentally delayed individuals. | Q52194359 | ||
A twin study of hyperactivity--I. An examination of hyperactivity scores and categories derived from Rutter teacher and parent questionnaires. | Q52245014 | ||
Response of children with ADHD to methylphenidate: interaction with internalizing symptoms. | Q52918729 | ||
Treatment effects of oral and transdermal clonidine in relation to methylphenidate: an open pilot study in ADD-H. | Q54140077 | ||
Propranolol for adults with temper outbursts and residual attention deficit disorder. | Q54143520 | ||
Combination of treatments for attention deficit hyperactivity disorder in adults. | Q54285099 | ||
Bupropion in children with attention deficit disorder. | Q55058469 | ||
The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine. | Q55065064 | ||
Pregnancy, delivery and infancy complications and attention deficit hyperactivity disorder: Issues of gene-environment interaction | Q57400583 | ||
Alterations in the vigilance performance of children receiving amitriptyline and methylphenidate pharmacotherapy | Q67532349 | ||
Effectiveness and tolerance of the selective MAO-A inhibitor moclobemide in children with hyperkinetic syndrome | Q67886081 | ||
Desipramine treatment of boys with attention-deficit hyperactivity disorder and tics: preliminary clinical experience | Q67980771 | ||
Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples | Q68030978 | ||
Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings | Q68135401 | ||
Bupropion treatment of attention-deficit hyperactivity disorder in adults | Q68344767 | ||
A case of Tourette's syndrome with symptoms of attention deficit disorder treated with desipramine | Q68734431 | ||
Genetic latent structure analysis of dysmorphology in attention deficit disorder | Q68750360 | ||
Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour | Q68953607 | ||
Modification of hyperkinetic behavior by nortriptyline | Q69472249 | ||
Effects of prenatal nicotine exposure on rat striatal dopaminergic and nicotinic systems | Q69730134 | ||
A twin study of hyperactivity--II. The aetiological role of genes, family relationships and perinatal adversity | Q69752281 | ||
The use of imipramine in children's behavior disorders | Q69930062 | ||
Postnatal behavioural effects of maternal nicotine exposure in rats | Q69931834 | ||
Desipramine in the treatment of attention deficit disorder in adolescents | Q70078701 | ||
Motor performance in hyperactive children treated with imipramine | Q70198159 | ||
A double-blind trial of bupropion in children with attention deficit disorder | Q70346356 | ||
An indication for use of imipramine in attention deficit disorder | Q70389424 | ||
The effects of cigarettes of varying yield on rapid information processing performance | Q70481863 | ||
A double-blind placebo controlled study of desipramine in the treatment of ADD: III. Lack of impact of comorbidity and family history factors on clinical response | Q70550342 | ||
Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome | Q70589135 | ||
Venlafaxine in adults with attention-deficit/hyperactivity disorder: an open clinical trial | Q71069802 | ||
Alcohol abuse and attention deficit disorder | Q71104338 | ||
Imipramine and methylphenidate in hyperactive children | Q71143748 | ||
Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children? | Q71465855 | ||
Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder. Clinical efficacy and side-effects | Q71532611 | ||
A naturalistic assessment of protriptyline for attention-deficit hyperactivity disorder | Q71819060 | ||
Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder | Q72290250 | ||
Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder | Q72298559 | ||
A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder | Q72373716 | ||
Estimation of the association between desipramine and the risk for sudden death in 5- to 14-year-old children | Q72614488 | ||
A naturalistic study of 24-hour electrocardiographic recordings and echocardiographic findings in children and adolescents treated with desipramine | Q72854517 | ||
ADHD is associated with early initiation of cigarette smoking in children and adolescents | Q72990183 | ||
Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder | Q77304921 | ||
P304 | page(s) | I51-9 | |
P577 | publication date | 2000-01-01 | |
P1433 | published in | European Child & Adolescent Psychiatry | Q15750166 |
P1476 | title | Non-stimulant treatments for ADHD. | |
P478 | volume | 9 Suppl 1 |
Q44736121 | A high-density single-nucleotide polymorphism screen of 23 candidate genes in attention deficit hyperactivity disorder: suggesting multiple susceptibility genes among Chinese Han population |
Q37107121 | A randomised controlled trial of the Neuro Emotional Technique (NET) for childhood Attention Deficit Hyperactivity Disorder (ADHD): a protocol |
Q21093202 | A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD |
Q98472628 | ADHD and DAMP: A General Health Perspective |
Q73434810 | Atomoxetine |
Q28279863 | Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder |
Q36673034 | Attention-deficit/hyperactivity disorder: neurophysiology, information processing, arousal and drug development. |
Q46622334 | Biophysical modeling of tonic cortical electrical activity in attention deficit hyperactivity disorder. |
Q30495118 | Chiropractic care for paediatric and adolescent Attention-Deficit/Hyperactivity Disorder: A systematic review |
Q34519657 | Donepezil for Alzheimer's disease: pharmacodynamic, pharmacokinetic, and clinical profiles. |
Q28246506 | Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults |
Q33760330 | Molecular genetics of attention deficit hyperactivity disorder |
Q36159618 | Molecular genetics of attention-deficit/hyperactivity disorder |
Q35868196 | Non-stimulant medications in the treatment of ADHD. |
Q35067434 | Novel duplication on chromosome 16 (q12.1-q21) associated with behavioral disorder, mild cognitive impairment, speech delay, and dysmorphic features: case report |
Q36613947 | Osmotic, controlled-release methylphenidate for the treatment of ADHD. |
Q37542382 | Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis. |
Q37273951 | Quantitative electroencephalography and attention-deficit/hyperactivity disorder: implications for clinical practice |
Q49393652 | Treatment of adult ADHD: a clinical perspective |
Q24243688 | Tricyclic antidepressants for ADHD in children and adolescents |
Q46697882 | Very early treatment with fluoxetine and reboxetine causing long-lasting change of the serotonin but not the noradrenaline transporter in the frontal cortex of rats |
Q73047448 | [Attention deficit hyperactivity disorder: diagnosis and drug therapy] |
Search more.